Home › Funds › Timothy G. Youngquist 2020 Irrevocable Trust › CNTX
Timothy G. Youngquist 2020 Irrevocable Trust position in CNTX
CONTEXT THERAPEUTICS INC · Health Care
Timothy G. Youngquist 2020 Irrevocable Trust reported holding 198,384 shares of CNTX (CONTEXT THERAPEUTICS INC) in its Q3 2026 13F filing — a position valued at US$60K, representing 0.01% of its reported portfolio and ranking #42 among its reported holdings. Timothy G. Youngquist 2020 Irrevocable Trust has disclosed CNTX holdings in 2 of the last 2 reported quarters, going back to Q2 2026.
Last updated: 2026-10-15 · Source: SEC EDGAR Form 13F-HR
How Timothy G. Youngquist 2020 Irrevocable Trust's CNTX position evolved
Timothy G. Youngquist 2020 Irrevocable Trust first disclosed a stake in CNTX in Q2 2026 at 198,384 shares (US$110K). Across 2 filings, Timothy G. Youngquist 2020 Irrevocable Trust held the position steady without any share-count change. The most recent filing (Q3 2026) shows 198,384 shares valued at US$60K.
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q2 2026 | 198.38K | $109.89K | New |
| Q3 2026 | 198.38K | $59.59K | Hold |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About CNTX and 13F data
CNTX (CONTEXT THERAPEUTICS INC) is a Health Care company. 37 other funds we track also report a position in CNTX — the largest reported positions include Nextech Invest Ltd. (US$4.1M), Avidity Partners Management LP (US$2.8M), Octagon Capital Advisors LP (US$1.7M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding CNTX
- Nextech Invest Ltd. 7.42M sh · $4.11M · Q2 2026
- Avidity Partners Management LP 5.00M sh · $2.77M · Q2 2026
- Octagon Capital Advisors LP 3.05M sh · $1.69M · Q2 2026
- Blue Owl Capital Holdings LP 2.93M sh · $1.63M · Q2 2026
- MPM BioImpact LLC 1.30M sh · $719.54K · Q2 2026
More on Timothy G. Youngquist 2020 Irrevocable Trust
FAQ
How long has Timothy G. Youngquist 2020 Irrevocable Trust held CNTX?
Timothy G. Youngquist 2020 Irrevocable Trust has disclosed CNTX holdings in 2 of the last 2 reported quarters, going back to Q2 2026.
What is Timothy G. Youngquist 2020 Irrevocable Trust's current position in CNTX?
As of Q3 2026, Timothy G. Youngquist 2020 Irrevocable Trust holds 198.38K shares of CNTX (CONTEXT THERAPEUTICS INC), valued at $59.59K, representing 0.01% of its reported portfolio and ranking #42.
Has Timothy G. Youngquist 2020 Irrevocable Trust been buying or selling CNTX?
In the latest 13F filing (Q3 2026), Timothy G. Youngquist 2020 Irrevocable Trust held unchanged its position in CNTX.
Which other funds hold CNTX?
Other major institutional holders of CNTX include Nextech Invest Ltd., Avidity Partners Management LP, Octagon Capital Advisors LP, among 37 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.